Chadi Nabhan, hematologist and medical oncologist, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X:
“Proud to share the partnership with ASCO as we leverage our Ryght
technology and site digital twins to accelerate the CDK4/6 breast cancer trial. Thank you Julie Gralow and a perfect start to ASCO26 – looking forward to sharing more at the meeting.”
ASCO Selects Ryght AI to Fast Track CDK4/6 Breast Cancer Clinical Trial
Other articles featuring Chadi Nabhan on OncoDaily.